A
Anne Bourrier
Researcher at University of Paris
Publications - 70
Citations - 4069
Anne Bourrier is an academic researcher from University of Paris. The author has contributed to research in topics: Inflammatory bowel disease & Vedolizumab. The author has an hindex of 22, co-authored 55 publications receiving 2923 citations. Previous affiliations of Anne Bourrier include Pierre-and-Marie-Curie University.
Papers
More filters
Journal ArticleDOI
CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands
Bruno Lamas,Mathias L. Richard,Valentin Leducq,Hang-Phuong Pham,Marie-Laure Michel,Grégory Da Costa,Chantal Bridonneau,Sarah Jegou,Thomas W. Hoffmann,Jane M. Natividad,Loic Brot,Soraya Taleb,Soraya Taleb,Aurélie Couturier-Maillard,Isabelle Nion-Larmurier,Fatiha Merabtene,Philippe Seksik,Anne Bourrier,Jacques Cosnes,Bernhard Ryffel,Bernhard Ryffel,Laurent Beaugerie,Jean-Marie Launay,Philippe Langella,Ramnik J. Xavier,Harry Sokol +25 more
TL;DR: In this article, a relationship between the host and the gut microbiota govern intestinal homeostasis is revealed, and the authors reveal that host genes affect the composition and function of the Gut microbiota, altering the production of microbial metabolites and intestinal inflammation.
Journal ArticleDOI
Fungal microbiota dysbiosis in IBD
Harry Sokol,Valentin Leducq,Hugues Aschard,Hang-Phuong Pham,Sarah Jegou,Cécilia Landman,David Cohen,David Cohen,Giuseppina Liguori,Anne Bourrier,Isabelle Nion-Larmurier,Jacques Cosnes,Philippe Seksik,Philippe Langella,David Skurnik,Mathias L. Richard,Laurent Beaugerie +16 more
TL;DR: It is observed that fungal microbiota is skewed in IBD, with an increased Basidiomycota/Ascomycota ratio, a decreased proportion of Saccharomyces cerevisiae and an increased proportion of Candida albicans compared with HS, indicating that a Crohn's disease-specific gut environment may favour fungi at the expense of bacteria.
Journal ArticleDOI
Early Administration of Azathioprine vs Conventional Management of Crohn's Disease: A Randomized Controlled Trial
Jacques Cosnes,Anne Bourrier,David Laharie,Stéphane Nahon,Yoram Bouhnik,Franck Carbonnel,Matthieu Allez,Jean Louis Dupas,Jean Marie Reimund,Guillaume Savoye,Pauline Jouet,Jacques Moreau,Jean Yves Mary,Jean-Frederic Colombel +13 more
TL;DR: Based on results from a clinical trial, administration of azathioprine within 6 months of diagnosis of CD was no more effective than conventional management in increasing time of clinical remission.
Journal ArticleDOI
Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study.
Yoram Bouhnik,Franck Carbonnel,David Laharie,Carmen Stefanescu,Xavier Hébuterne,Vered Abitbol,Maria Nachury,Hedia Brixi,Arnaud Bourreille,Laurence Picon,Anne Bourrier,Matthieu Allez,Laurent Peyrin-Biroulet,Jacques Moreau,Guillaume Savoye,Mathurin Fumery,Stéphane Nancey,Xavier Roblin,Romain Altwegg,Guillaume Bouguen,Gilles Bommelaer,Silvio Danese,Edouard Louis,Magaly Zappa,Jean-Yves Mary +24 more
TL;DR: A successful response to adalimumab was observed in about two-thirds of CD patients with SSBS and was prolonged in nearly half of them till the end of follow-up, and more than half of the patients were free of surgery 4 years after treatment initiation.
Journal ArticleDOI
Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study
Harry Sokol,Cécilia Landman,Philippe Seksik,Laurence Berard,Melissa Montil,Isabelle Nion-Larmurier,Anne Bourrier,Guillaume Le Gall,Valérie Lalande,Alexis de Rougemont,Julien Kirchgesner,Anne Daguenel,Marine Cachanado,Alexandra Rousseau,Elodie Drouet,Michelle Rosenzwajg,Hervé Hagege,Xavier Dray,David Klatzman,Philippe Marteau,Laurent Beaugerie,Tabassome Simon +21 more
TL;DR: Higher colonization by donor microbiota was associated with maintenance of remission and no safety signal was identified in this pilot study in adults with colonic or ileo-colonic CD.